Search research articles
Contact Us
Filters
Showing results (31-40 of 187) with videos related to
Page
of 19
Sort By:
Sleep Medicine
|
September 3, 2004
Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS
Clete A Kushida, Richard P Allen, Mark J Atkinson
Sleep Medicine
|
June 17, 2017
High prevalence of restless legs syndrome/Willis Ekbom Disease (RLS/WED) among people living at high altitude in the Indian Himalaya
Ravi Gupta, Jan Ulfberg, Richard P Allen, et al.
Sleep Medicine
|
November 9, 2016
Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome
Yong Won Cho, Richard P Allen, Christopher J Earley
Sleep Medicine
|
January 22, 2013
Lower molecular weight intravenous iron dextran for restless legs syndrome
Yong Won Cho, Richard P Allen, Christopher J Earley
Sleep Medicine
|
February 21, 2018
Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome
Yong Won Cho, Richard P Allen, Christopher J Earley
Current Opinion in Neurology
|
June 29, 2010
Update in restless legs syndrome
Rachel E Salas, Charlene E Gamaldo, Richard P Allen
Sleep Medicine
|
January 18, 2011
A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome
Nathan Silver, Richard P Allen, Julia Senerth, et al.
Sleep Medicine
|
February 6, 2016
Inter-movement interval as a primary stable measure of periodic limb movements of sleep
Patrick Skeba, Kasidet Hiranniramol, Christopher J Earley, et al.
Sleep Medicine
|
December 3, 2014
Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease)
Tahir Mehmood, Michael Auerbach, Christopher J Earley, et al.
Geriatrics
|
October 10, 2007
Restless legs syndrome: nonpharmacologic and pharmacologic treatments
John W Winkelman, Richard P Allen, Penny Tenzer, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 187) with videos related to
Sort By:
Page
of 19
Sleep Medicine
|
September 3, 2004
Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS
Clete A Kushida, Richard P Allen, Mark J Atkinson
Sleep Medicine
|
June 17, 2017
High prevalence of restless legs syndrome/Willis Ekbom Disease (RLS/WED) among people living at high altitude in the Indian Himalaya
Ravi Gupta, Jan Ulfberg, Richard P Allen, et al.
Sleep Medicine
|
November 9, 2016
Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome
Yong Won Cho, Richard P Allen, Christopher J Earley
Sleep Medicine
|
January 22, 2013
Lower molecular weight intravenous iron dextran for restless legs syndrome
Yong Won Cho, Richard P Allen, Christopher J Earley
Sleep Medicine
|
February 21, 2018
Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome
Yong Won Cho, Richard P Allen, Christopher J Earley
Current Opinion in Neurology
|
June 29, 2010
Update in restless legs syndrome
Rachel E Salas, Charlene E Gamaldo, Richard P Allen
Sleep Medicine
|
January 18, 2011
A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome
Nathan Silver, Richard P Allen, Julia Senerth, et al.
Sleep Medicine
|
February 6, 2016
Inter-movement interval as a primary stable measure of periodic limb movements of sleep
Patrick Skeba, Kasidet Hiranniramol, Christopher J Earley, et al.
Sleep Medicine
|
December 3, 2014
Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease)
Tahir Mehmood, Michael Auerbach, Christopher J Earley, et al.
Geriatrics
|
October 10, 2007
Restless legs syndrome: nonpharmacologic and pharmacologic treatments
John W Winkelman, Richard P Allen, Penny Tenzer, et al.
Page
of 19